PASADENA – The World Stem Cell Summit, now in its seventh year, will kick off three days of networking and seminars on Monday at the Pasadena Convention Center in hopes of spurring progress and investment in the emerging industry. The event promises more than 150 top international speakers and 50 hours of programming with industry leaders from science, pharmaceuticals, business, policy, ethics, law and more. Bernie Siegel, founder and co-chair of the Summit and executive director the Genetic Policy Institute (GPI), which produces the event, said this year’s focus on translational regenerative medicine is about asking “how do you take the phenomenal scientific research going on in labs and translate it into medical treatments? It’s a big job to do this, and more than just the science.”
Recent Posts
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise
- New Cell Therapy For Resistant Hodgkins Patients
- Cracking the code to scalable cell and gene therapy